Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311752 Substituted pyridazine derivatives
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311747 Dicycloazaalkane derivates, preparation processes and medical uses thereof
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311737 Pyrimido [4,5-b] -oxazines for use as dgat inhibitors
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311727 Therapeutic amine-arylsulfonamide conjugate compounds
12/09/2010US20100311720 Spiroindoline Modulators of Muscarinic Receptors
12/09/2010US20100311719 Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication
12/09/2010US20100311717 Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
12/09/2010US20100311710 Cyclobutanemethanamine inhibitors of monoamine reuptake
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311690 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
12/09/2010US20100311673 Sulfanyl-tetrahydropyran-based compounds and methods of their use
12/09/2010US20100311672 Vesiculins
12/09/2010US20100311651 Use of glp-1 compound for treatment of critically ill patients
12/09/2010US20100311650 Treatment for obesity
12/09/2010US20100311649 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311647 Use of melanocortins to treat insulin sensitivity
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100310677 Stable amorphous calcium carbonate comprising phosphorylated amino acids
12/09/2010US20100310673 Substance and composition both capable of imparting heat resistance
12/09/2010US20100310664 Compositions and methods for treating insulin resistance and diabetes mellitus
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310607 Pharmaceutical formulations
12/09/2010US20100310599 Orally Bioavailable Lipid-Based Constructs
12/09/2010US20100310588 Regulatory t cells suppress autoimmunity
12/09/2010US20100310578 Use of lipocalin-2 as a diagnostic marker and therapeutic target
12/09/2010US20100310577 Methods for increasing thermogenic adipocytes
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310566 Fibroblast Growth Factor-Like Polypeptides
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310493 Acetamide derivatives as glucokinase activators, their process and medicinal application
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010CA2764449A1 Nucleic acid modulators of glycoprotein vi
12/09/2010CA2764021A1 Gpr 119 modulators
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2763529A1 Compositions and methods modulating mg29 for the treatment of diabetes
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2257546A2 Functionally selective alpha2c adrenoreceptor agonists
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257286A1 Treatment of energy utilization disease
12/08/2010EP2257187A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird
12/08/2010EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1455821B1 Parathyroid hormone antibodies and related methods
12/08/2010EP0916345B1 Human growth hormone for treating anorexia nervosa
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1939506B Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method
12/08/2010CN1829504B Amino acid composition and supplementary liquid containing the same
12/08/2010CN1814123B Chinese medicine composition for treating diabetes and its preparation method
12/08/2010CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine
12/08/2010CN1736230B Fat-lowering weight-decreasing tea and preparation process thereof
12/08/2010CN1709409B Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1620453B Thiazolidinedione derivative and its use as antidiabetic
12/08/2010CN1496741B Method for producing enteric nutrient containing malt ketose
12/08/2010CN1434681B Method for maintaining or improving the synthesis of mucins
12/08/2010CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101910184A Solubilized thiazolopyridines
12/08/2010CN101910171A Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappa B activity and use thereof
12/08/2010CN101910169A Bicycloamine derivative
12/08/2010CN101910162A Cyclic pyridyl-N-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910150A 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
12/08/2010CN101910131A Carboxamide, sulfonamide and amine compounds for metabolic disorders
12/08/2010CN101909640A Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
12/08/2010CN101909639A Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
12/08/2010CN101909629A Crystalline (R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
12/08/2010CN101909621A 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
12/08/2010CN101909619A Composition comprising sesamin component and quercetin glycoside
12/08/2010CN101909610A Composition for oral administration
12/08/2010CN101909609A Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
12/08/2010CN101909604A Method of treating dysglycemia and glucose excursions
12/08/2010CN101909591A Emulsion preparation for external application to skin and cosmetic
12/08/2010CN101909590A Preparation for external application to skin and cosmetic preparation
12/08/2010CN101909468A Liquid enteral nutritional composition with a low specific protein volume
12/08/2010CN101906158A Pegylation hypoglycemic polypeptide and preparation method and application thereof
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 1298